BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Sciona Closes $6.5 Million Financing


4/6/2006 10:18:42 AM

BOULDER, Colo., April 5 /PRNewswire/ -- Sciona, Inc., a world leader in the area of personalized genetics, announced today that it has successfully closed a $6.5 million private round raised from its current venture investors. The funds will be used to continue the development of Sciona's nutra-genetics business. The financing participants included DSM Venturing, Prelude Trust, Burrill and Company, BioVentures Inc., BASF Venture Capital, and Semola Limited.

Sciona has developed and is marketing Cellf(TM), a proprietary DNA screen for critical gene variants that, when correlated to an individual's diet, provides specific personalized recommendations for food or nutrient intake to enhance health and wellness. Sciona's genetic personalization technology provides individual access to non-medical genetic data in absolute privacy.

Chris Martin, Sciona founder and chairman said, "Sciona believes that breakthroughs in the collection and analysis of genetic data will allow us to meet the growing demand of a more health conscious population desiring customized, direct access to personalized health information. The proprietary Cellf(TM) kit is the leading product supplying non-medical genetic data directly to consumers."

The Cellf(TM) testing procedure uses cheek-swab technology that allows individuals to collect their own DNA samples in the privacy of their home. Because Sciona provides its services directly to individuals, it is able to assure absolute privacy for the genetic data and its interpretation, giving the consumer total control of the decision of whom to share their data with.

About Sciona: Sciona provides personalized health and nutrition recommendations based on an individual's diet, lifestyle and unique genetic profile. The company has created a powerful set of tools enabling consumers and consumer product companies to harness the scientific information derived from the Human Genome Project. For additional information, visit www.sciona.com.

Sciona, Inc.

CONTACT: Jack McGovern of Sciona, Inc., +1-303-442-4300; or Press, JanStrode, +1-619-890-4040, for Sciona, Inc.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES